The Potential Role of Urinary Microbiome in Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2022 Aug 26

PMID 36010213

Authors

Seong Hyeon Yu

Seung Il Jung

Affiliations

Soon will be listed here.

Abstract

Historically, urine in the urinary tract was considered "sterile" based primarily on culture-dependent methods of bacterial detection. Rapidly developing sequencing methods and analytical techniques have detected bacterial deoxyribonucleic acid and live bacteria in urine, improving our ability to understand the urinary tract microbiome. Recently, many studies have revealed evidence of a microbial presence in human urine in the absence of clinical infections. In women, fascinating evidence associates urinary tract microbiota with lower urinary tract symptoms (LUTS). However, the association between urinary tract microbiota and men with LUTS, particularly those with benign prostate hyperplasia (BPH), has not been established. In addition, the identification of the proinflammatory cytokines and pathogens responsible for the clinical progression of BPH is still underway. This review article aimed to address microbiome-related evidence for BPH. Further studies are required for a comprehensive understanding of the relationship between the urogenital microbiome and BPH pathogenesis to facilitate the development of preventive and therapeutic approaches for male LUTS.

Citing Articles

NK Cell-Microbiota Interaction Biomarker Strategy: Advancing Prostate Cancer Management.

Fanijavadi S, Hansen T, Zedan A Biomolecules. 2025; 15(2).

PMID: 40001576 PMC: 11852595. DOI: 10.3390/biom15020273.

Analysis of the Beneficial Effects of Probiotics on the Gut-Prostate Axis Using Prostatic Co-Culture Model.

Ferrari S, Galla R, Mule S, Uberti F Foods. 2024; 13(22).

PMID: 39594064 PMC: 11593767. DOI: 10.3390/foods13223647.

Lactobacillus-Polydopamine System for Targeted Drug Delivery in Overactive Bladder: Evidence from Bladder Cell Spheroids, Rat Models, and Urinary Microbiome Profiling.

Wang X, Wang G, Cen P, Lan H, Guo L, Yisha Z Int J Nanomedicine. 2024; 19:8353-8371.

PMID: 39161357 PMC: 11332418. DOI: 10.2147/IJN.S465745.

Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities.

Kim S, Park M, Choi A, Yoo S Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256945 PMC: 10819128. DOI: 10.3390/ph17010112.

BMI and BPH correlate with urinary microbiome diversity and lower urinary tract symptoms in men.

Bowie K, Garzotto M, Orwoll E, Karstens L bioRxiv. 2024; .

PMID: 38168244 PMC: 10760175. DOI: 10.1101/2023.12.14.571758.

References

Jain S, Samal A, Das B, Pradhan B, Sahu N, Mohapatra D . Escherichia coli, a common constituent of benign prostate hyperplasia-associated microbiota induces inflammation and DNA damage in prostate epithelial cells. Prostate. 2020; 80(15):1341-1352. DOI: 10.1002/pros.24063. View

Ficarra V, Rossanese M, Zazzara M, Giannarini G, Abbinante M, Bartoletti R . The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy. Curr Urol Rep. 2014; 15(12):463. DOI: 10.1007/s11934-014-0463-9. View

Roehrborn C . Pathology of benign prostatic hyperplasia. Int J Impot Res. 2008; 20 Suppl 3:S11-8. DOI: 10.1038/ijir.2008.55. View

Bechis S, Otsetov A, Ge R, Olumi A . Personalized medicine for the management of benign prostatic hyperplasia. J Urol. 2014; 192(1):16-23. PMC: 4143483. DOI: 10.1016/j.juro.2014.01.114. View

Nagamatsu K, Hannan T, Guest R, Kostakioti M, Hadjifrangiskou M, Binkley J . Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc Natl Acad Sci U S A. 2015; 112(8):E871-80. PMC: 4345586. DOI: 10.1073/pnas.1500374112. View

Garretto A, Thomas-White K, Wolfe A, Putonti C . Detecting viral genomes in the female urinary microbiome. J Gen Virol. 2018; 99(8):1141-1146. PMC: 6171713. DOI: 10.1099/jgv.0.001097. View

Lough M, Shradar E, Hsieh C, Hedlin H . Contamination in Adult Midstream Clean-Catch Urine Cultures in the Emergency Department: A Randomized Controlled Trial. J Emerg Nurs. 2019; 45(5):488-501. DOI: 10.1016/j.jen.2019.06.001. View

Nickel J, Stephens A, Landis J, Mullins C, Van Bokhoven A, Lucia M . Assessment of the Lower Urinary Tract Microbiota during Symptom Flare in Women with Urologic Chronic Pelvic Pain Syndrome: A MAPP Network Study. J Urol. 2015; 195(2):356-62. PMC: 4770794. DOI: 10.1016/j.juro.2015.09.075. View

Frolund M, Wikstrom A, Lidbrink P, Abu Al-Soud W, Larsen N, Harder C . The bacterial microbiota in first-void urine from men with and without idiopathic urethritis. PLoS One. 2018; 13(7):e0201380. PMC: 6063444. DOI: 10.1371/journal.pone.0201380. View

10.

Wilson J . The critical role of androgens in prostate development. Endocrinol Metab Clin North Am. 2011; 40(3):577-90, ix. DOI: 10.1016/j.ecl.2011.05.003. View

11.

Hollingsworth J, Wei J . Economic impact of surgical intervention in the treatment of benign prostatic hyperplasia. Rev Urol. 2006; 8 Suppl 3:S9-S15. PMC: 1686802. View

12.

Gandaglia G, Zaffuto E, Fossati N, Cucchiara V, Mirone V, Montorsi F . The role of prostatic inflammation in the development and progression of benign and malignant diseases. Curr Opin Urol. 2016; 27(2):99-106. DOI: 10.1097/MOU.0000000000000369. View

13.

Chughtai B, Lee R, Te A, Kaplan S . Role of inflammation in benign prostatic hyperplasia. Rev Urol. 2011; 13(3):147-50. PMC: 3221555. View

14.

Aragon I, Herrera-Imbroda B, Queipo-Ortuno M, Castillo E, Del Moral J, Gomez-Millan J . The Urinary Tract Microbiome in Health and Disease. Eur Urol Focus. 2017; 4(1):128-138. DOI: 10.1016/j.euf.2016.11.001. View

15.

Winter B, OConnell H, Bowden S, Carey M, Eisen D . A Case Control Study Reveals that Polyomaviruria Is Significantly Associated with Interstitial Cystitis and Vesical Ulceration. PLoS One. 2015; 10(9):e0137310. PMC: 4556646. DOI: 10.1371/journal.pone.0137310. View

16.

Kashyap M, Pore S, Wang Z, Gingrich J, Yoshimura N, Tyagi P . Inflammasomes are important mediators of prostatic inflammation associated with BPH. J Inflamm (Lond). 2015; 12:37. PMC: 4436794. DOI: 10.1186/s12950-015-0082-3. View

17.

Shoemaker R, Kim J . Urobiome: An outlook on the metagenome of urological diseases. Investig Clin Urol. 2021; 62(6):611-622. PMC: 8566783. DOI: 10.4111/icu.20210312. View

18.

Wolfe A, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M . Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012; 50(4):1376-83. PMC: 3318548. DOI: 10.1128/JCM.05852-11. View

19.

Takeuchi O, Akira S . Pattern recognition receptors and inflammation. Cell. 2010; 140(6):805-20. DOI: 10.1016/j.cell.2010.01.022. View

20.

Dong Q, Nelson D, Toh E, Diao L, Gao X, Fortenberry J . The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLoS One. 2011; 6(5):e19709. PMC: 3094389. DOI: 10.1371/journal.pone.0019709. View